Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 17,768 shares at $13.84 ($245K) on 2019-01-02, disclosed to the SEC on 2019-01-04.
Open-market sale of $245k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.84 | 7,768 | $108K | 43.9% |
| 2 | $13.84 | 7,768 | $108K | 43.9% |
| 3 | $13.48 | 2,232 | $30K | 12.3% |
| Total | $13.79 avg | 17,768 | $245K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |